Floatz logo

aciclovir

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive

City of Hope Medical CenterSmall moleculePhase 2Active
B
58/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
81/ 100

Competitive context

16 Active assets in the Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive cohort.

Asset / SponsorPhaseRating
METHOTREXATE
M.D. Anderson Cancer Center
Phase 3BBB
Venetoclax
Children's Hospital Medical Center, Cincinnati
Phase 2BB
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
OHSU Knight Cancer Institute
Phase 3BB
Ponatinib
Otsuka Beijing Research Institute
Phase 2BB
DEXAMETHASONE
M.D. Anderson Cancer Center
Phase 2BB

View all 50 →

Same molecule, other indications

aciclovir is also rated in:

herpes simplex infectious diseaseDormant
BBB
Indicative ·
72 / 100
View asset →
relapsing-remitting multiple sclerosisDormant
BB
Indicative ·
68 / 100
View asset →
herpes zosterDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →